Kopran Ltd.

KOPRAN Share PricePharmaceuticals & Drugs

182.55

6.9 (3.9%)

As on October 3, 2025

Exchange Scrips: BSE524280NSEKOPRANISININE082A01010

Market Cap878 Cr

P/E Ratio 22.86

Dividend Yield 0.16 %

Performance

Market performance

Open175.62
High184
Volumes2,12,138
Prev182.55
Low174.62
As on2025-10-03

Historical performance

1 Year High329
3 Year High369.7
5 Year High370.45
1 Year Low154.06
3 Year Low96
5 Year Low86.7

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
878
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
22.86
Dividend Yield
Dividend Yield
0.16 %

Investment Returns

1 Year
-44.1%
3 Years
16.2%
5 Years
101.4%
10 Years
245.4%

Technicals

IndicatorsValueSignal
5-DMA175.37Bullish
10-DMA176.44Bullish
20-DMA177.4Bullish
50-DMA168.52Bullish
100-DMA177.22Bullish
200-DMA183.55Bearish

Shareholding Pattern

FieldJun-2025Mar-2025Dec-2024Sep-2024Jun-2024
Promoters1718192020
Foreign Investors---------------
Domestic Investors1718192020
Public Investors6017658633605405713351472
Government---------------

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 22.86.
  • 3Y Stock Price CAGR of the stock is 4.0.
  • The stock has a beta of 1.6.
  • In the last financial year, the company had an EBITDA of ₹769 Million.
  • The company generated revenue of ₹6296 Million in the previous financial year.

Kopran Ltd.

182.556.9   (3.9%)

Investment Amount: ₹ 1000000
Current Value: ₹ 621658.4
No. of Shares: 3405 (Approx)
Performance:-37.8%
P/L: ₹-378341.6

Top Gainers

SymbolChange%
ORIENTTECH425.15(20%)
ATLANTAA55.65(20%)
AAATECH105.28(20%)
KIOCL528.8(20%)
ORISSAMINE5656.7(19%)

Top Losers

SymbolChange%
CENTUM2459.2(-9%)
SIGMA53.605(-8%)
STYLEBAAZA354.05(-6%)
TATAINVEST10002(-6%)
EUROTEXIND14.65(-5%)
LCCINFOTEC4.71(-5%)
SHANKARA178.15(-5%)
UNIMECH989.8(-5%)

Peer Comparison

Bafna Pharmaceuticals Ltd.

64.4%

169.26

1 Month Performance

Anlon Healthcare Ltd.

38.3%

126.84

1 Month Performance

Lasa Supergenerics Ltd.

34.6%

11.76

1 Month Performance

Themis Medicare Ltd.

28.5%

132.54

1 Month Performance

Vineet Laboratories Ltd.

25.7%

42.75

1 Month Performance

Natural Capsules Ltd.

25.2%

259.2

1 Month Performance

Medico Remedies Ltd.

21%

48.84

1 Month Performance

Aarey Drugs & Pharmaceuticals Ltd.

18.1%

82.22

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month